Wednesday, August 21, 2019

Recent Trends in Oncology


Research reveals that combo of palbociclib & cetuximab shows antitumor activity for platinum or cetuximab resistant HPV unrelated head and neck squamous cell carcinoma. Explore more about cancer at: http://bit.ly/2K4sRl4



No comments:

Post a Comment